期刊文献+

慢性心力衰竭合并贫血的研究进展 被引量:8

Progress of Anemia in Chronic Heart Failure
原文传递
导出
摘要 心力衰竭是是临床上常见的急症,也是心血管疾病当中许多器质性心脏病晚期的并发症,其有较高的发病率和死亡率,并且严重影响着心血管疾病患者的生活质量。近些年来越来越多的国内外研究证明慢性心力衰竭患者常合并贫血,并且发病率随着心脏损害程度加重而增加。贫血与慢性心衰患者的生活质量及预后密切相关,其发病原因是多因素且较复杂的,治疗也是多方面的,本文主要概括近些年来国内外研究对慢性心力衰竭合并贫血有关的认识和进展。 Chronic heart failure (CHF) is a common acute disease, and it is also the late complications of the various causes of structural heart disease in clinical, with severe morbidity and mortality, which Seriously endangers the health of human. Many studies have found a high prevalence of anemia in patients with CHF, and the ratio is increasingly grows with the degree of heart damage in recent years. In heart failure patients, anemia is associated with quality of life and Prognosis. The pathogenesis and therapies are complex and multifactorial. This article reviews the progress of Anemia in chronic heart failure in recent years.
出处 《现代生物医学进展》 CAS 2014年第17期3377-3379,3388,共4页 Progress in Modern Biomedicine
关键词 慢性心力衰竭 贫血 病因 治疗 进展 Chronic heart failure Anemia Pathogenesis Therapies Progress
  • 相关文献

参考文献36

  • 1GroenveldHF, Januzzi J L, Damman K, et al.Anemia and mortality inheart failure patients a systematic review and meta-analysis[J]. J AmColl Cardiol, 2008, 52(10): 818-827.
  • 2SalisburyA C, Kosiborod M. Outcomes associated with anemia in patientswith heart failure[J]. Heart Fail Clin, 2010, 6(3):359-372.
  • 3Kalra P R, Bolger A P, Francis D P, et al. Effect of anemia on exercisetolerance in chronic heart failure in men[J]. AmJ Cardiol, 2003,91(7):888-891.
  • 4Adams KJ, Pina I L, Ghali J K, et al. Prospective evaluation of the associationbetween hemoglobin concentration and quality of life inpatients with heart failure [J]. AmHeart J, 2009,158(6):965-971.
  • 5von Haehling S, van VeldhuisenD J, Roughton M, et al. Anaemia amongpatients with heart failure and preserved or reduced ejectionfraction: results from the SENIORS study [J]. Eur J Heart Fail,2011,13(6):656-663.
  • 6Lindenfeld J. Prevalence of anemia and effects on mortality in patientswith heart failure[J]. AmHeart J, 2005,149(3):391-401.
  • 7Smith GL, Lichtman J H, BrackenMB, et al. Renal impairment andoutcomes in heart failure: systematic reviewand meta-analysis[J]. JAmColl Cardiol, 2006,47(10):1987-1996.
  • 8SilverbergD S, Wexler D, BlumM, et al. The cardio renal anemia syndrome:correcting anemia in patients with resistant congestive heart failurecan improve both cardiac and renal function and reduce hospitalizations[J]. Clin Nephrol, 2003,60(Suppl 1):S93-S102.
  • 9AroraN P, Ghali J K. Iron deficiency anemia in heart failure [J]. HeartFail Rev, 2012.
  • 10Okonko DO, Mandal AK, MissourisC G, et al. Disordered iron homeostasisin chronic heart failure: prevalence, predictors, and relationto anemia, exercise capacity, and survival [J]. J Am Coll Cardiol, 20-11,58(12):1241-1251.

二级参考文献46

  • 1王征,王琳,董念国.人重组促红细胞生成素对离体心肌缺血再灌注损伤保护机制初步探讨[J].中国现代医学杂志,2006,16(18):2729-2733. 被引量:4
  • 2GOTTLIEB R A, BURLESON K O, KLONER R A, et al. Reperfusion injury induces apoptosis in rabbit cardiomyoeytes [J]. J Clin Invest, 1994, 94:1621 - 1628.
  • 3SARASTE A, PULKKI K, KALLAJOK M, et al. Apoptosis in human acute myocardial infarction [J]. Circulation, 1997, 95: 320-323.
  • 4CAI Z, MANALO D J, WEI G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury [J]. Circulation,2003,108 : 79-85.
  • 5JAQUET K,KRAUSE K,TAWAKOL-KHODAI M, et al. Erythropoietin and VEGF exhibit equal angiogenic potential [J]. Microvasc Res, 2002, 64:326 - 333.
  • 6SHINGO T, SOROKAN S T, SHIMAZAKI T. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells [J]. J Neurosci, 2001,21:9733 -9743.
  • 7BULLARD A J, GOVEWALLA P, YELLON D M. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo[J]. Basic Res Cardiol, 2005,100 : 397 - 403.
  • 8WRIGHT G L, HANLON P, AMIN K, et al. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury[J]. FASEB J,2004, 18: 1031-1033.
  • 9RAFIEE P, SHI Y, SU J, et al. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways[J]. Basic Res Cardiol, 2005,100 : 187 - 197.
  • 10MANCINI D M,KATZ S D,LANG C C, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure [J]. Circulation, 2003,107 : 294 - 299.

共引文献24

同被引文献72

引证文献8

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部